StageZero Life Sciences Ltd T.SZLS

Alternate Symbol(s): SZLSF

Healthcare Biotechnology

StageZero Life Sciences, Ltd. is a Canada-based vertically integrated healthcare company. The Company is engaged in improving the early detection and management of cancer and other chronic diseases through diagnostics and telehealth programs that provide clinical interventions to assist patients who have cancer (COC Protocol), and help patients reduce the risk of developing late-stage disease (AVRT). Its test, Aristotle, is the first mRNA multi-cancer panel for simultaneously screening for multiple cancers from a single sample of blood with high sensitivity and specificity for each cancer. Aristotle uses mRNA technology to identify the molecular signatures of multiple cancer types and is built on the Company's patented technology platform, the Sentinel Principle. The Care Oncology Clinic offers a supervised treatment regimen (the COC Protocol) for people diagnosed with cancer of any type or stage. Its ColonSentry is a proprietary blood test for screening for Colorectal Cancer.

TSX:SZLS - Post by User

StageZero Life Sciences Ltd > Getting excited for the week ahead

<< Previous

Bullboard Posts

Next >>

Comment by MarketMoneyon Mar 21, 2021 7:07pm

130 Views

Post# 32847799

RE:RE:RE:RE:RE:RE:RE:Getting excited for the week ahead

And I would add for the excitement with Aristotle launch is it will attract fundamentals trader :-)

Technical trader are already in, just missing all the fundamental traders who are waiting for proof of a good launching haha

All good as we will get a nice long term prosperity with Aristotle! Long live to Aristole!

StageZero learned from the launch of ColonSentry and from certain partners/clients.....The charts says we are READY! Never been this ready since 2006!

<< Previous

Bullboard Posts

Next >>

Options trading in a volatile macro environment